Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youki Ueda

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Plos One|February 21, 2015
Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotypeShinya Satoh, Kyoko Mori, Youki Ueda, et al.
The Biochemical Journal|December 16, 2018
Ribavirin-induced down-regulation of CCAAT/enhancer-binding protein α leads to suppression of lipogenesisShinya Satoh, Daichi Onomura, Youki Ueda, et al.
Plos One|March 15, 2014
Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systemsNobuyuki Kato, Hiroe Sejima, Youki Ueda, et al.
Biochemical and Biophysical Research Communications|May 29, 2019
A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infectionYouki Ueda, Weilin Gu, Hiromichi Dansako, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replicationShintaro Ban, Youki Ueda, Masao Ohashi, et al.
The FEBS Journal|October 17, 2015
The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assemblyHiromichi Dansako, Youki Ueda, Nobuaki Okumura, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2014
Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogsKenji Matsuno, Youki Ueda, Miwa Fukuda, et al.
Cancer Science|February 10, 2023
Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunityTomofumi Watanabe, Takamasa Ishino, Youki Ueda, et al.
Archives of Virology|December 14, 2019
Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell cultureNobuyuki Kato, Youki Ueda, Hiroe Sejima, et al.
Virus Research|March 22, 2017
Evaluation of preclinical antimalarial drugs, which can overcome direct-acting antivirals-resistant hepatitis C viruses, using the viral reporter assay systemsYouki Ueda, Hiromichi Dansako, Shinya Satoh, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Plos One|February 21, 2015
Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotypeShinya Satoh, Kyoko Mori, Youki Ueda, et al.
The Biochemical Journal|December 16, 2018
Ribavirin-induced down-regulation of CCAAT/enhancer-binding protein α leads to suppression of lipogenesisShinya Satoh, Daichi Onomura, Youki Ueda, et al.
Plos One|March 15, 2014
Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systemsNobuyuki Kato, Hiroe Sejima, Youki Ueda, et al.
Biochemical and Biophysical Research Communications|May 29, 2019
A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infectionYouki Ueda, Weilin Gu, Hiromichi Dansako, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replicationShintaro Ban, Youki Ueda, Masao Ohashi, et al.
The FEBS Journal|October 17, 2015
The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assemblyHiromichi Dansako, Youki Ueda, Nobuaki Okumura, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2014
Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogsKenji Matsuno, Youki Ueda, Miwa Fukuda, et al.
Cancer Science|February 10, 2023
Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunityTomofumi Watanabe, Takamasa Ishino, Youki Ueda, et al.
Archives of Virology|December 14, 2019
Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell cultureNobuyuki Kato, Youki Ueda, Hiroe Sejima, et al.
Virus Research|March 22, 2017
Evaluation of preclinical antimalarial drugs, which can overcome direct-acting antivirals-resistant hepatitis C viruses, using the viral reporter assay systemsYouki Ueda, Hiromichi Dansako, Shinya Satoh, et al.
Pageof 4